October 21, 2019. Vinicius Bagnarolli, rfxcel’s director of operations for Latin America, will speak about serialization best practices, preparing for Brazil’s National Medicine Control System
October 16, 2019, 2019. rfxcel, the global leader in supply chain track and trace solutions and the pharma industry’s thought leader in the Verification Router Service (VRS), will exhibit at the
October 9, 2019. Members of rfxcel’s Food and Beverage Team will be at the PMA Fresh Summit 2019 to talk about the changing landscape of food production, distribution, and marketing, and how
By: Tea Rajic March 14, 2019
October 15, 2018
rfxcel announced today that they will expand their capability to enable LATAM Life Science(s) organizations to meet serialization and regulatory compliance requirements throughout Latin America and
rfxcel now has fully integrated “edge” functionality for warehouse, distribution and re-work operations (Warehouse Edge System).
March 6, 2018: rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is one of two companies recognized by the HDA (Healthcare Distribution Alliance) for
February 21, 2018: Pharmaceuticals and medical devices provider DCC Vital chooses rfxcel, a Pharma track and trace company, as Falsified Medicines Directive and Serialisation Solution Provider.
February 7, 2018: rfxcel, the leader in Life Science track and trace, and compliance systems, today announced the release of rfxcel Traceability System (rTS) 6.0. The new traceability software
December 21, 2017: rfxcel, a global Track & Trace company, has been confirmed as a Technically Certified Connection Provider by the European Medicines Verification Organization (EMVO).
As part of rfxcel’s continued commitment to serve its global customers, rfxcel is pleased to announce that key leaders in track and trace join rfxcel Executive Team to drive global growth.
rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is pleased to announce the acquisition of assets from Frequentz, Inc., a leading player in life science
Global pharmaceutical safety through smart serialization and open collaboration. The need for pharmaceutical companies to have absolute and accurate visibility of their supply chains is imperative.
rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories.
August 3, 2017: rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners. Kayne Partners is the
January 4, 2017: rfXcel the leader in serialization, traceability, and DSCSA and global compliance for the Pharmaceutical and Life Sciences industries, today announced the promotion of Brian Bilyeu
November 2, 2016: rfXcel and Be4ward announce that they will co-host an informative webinar on November 16, 2016 for Contract Manufactures. This session will help clarify some of the confusion
July 26, 2016: rfXcel SNAP product will be made available to all Premier members at preferred pricing San Ramon, Calif. & Charlotte, N.C., July 26, 2016 – rfXcel, the leader in
Verizon Extends Healthcare Focus to Pharmaceutical Sector with rfxcel
Vikash Pushpraj OCTOBER 28, 2018
January 31, 2019 | By Jack Tarkoff
April 12, 2019
October 30, 2018
Ready or not, we’re all pretty much up to speed with the objectives of the Falsified Medicines Directive (FMD), which comes into force on 9 February 2019. Created to prevent counterfeit medicines
We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW!
How a quality-first approach to serialization can deliver long-term value beyond compliance.
Vinicius Bagnarolli, Director of Operations in Latin America for rfxcel, says the time to start preparing is now.
Global pharma is teetering on the brink of a new world in which ground-breaking regulations impose strict serialization, traceability, and verification obligations on the medicine supply chain. With
Here, rfxcel CEO Glenn Abood explains how serialisation software can unlock additional value beyond regulatory compliance.